EXHIBIT 10.21 CERTIFICATE OF DESIGNATION of the PREFERENCES, RIGHTS, LIMITATIONS, QUALIFICATIONS AND RESTRICTIONS of the SERIES B SUPER VOTING PREFERRED STOCK of CHAMPION PAIN CARE CORPORATION

EX-10.21 3 f1021.htm EXHIBIT 10.21 Certificate of Designations - Series A Preferred Tarsier Ltd (01295782-2).DOC



EXHIBIT 10.21


CERTIFICATE OF DESIGNATION

of the

PREFERENCES, RIGHTS, LIMITATIONS, QUALIFICATIONS AND RESTRICTIONS

of the

SERIES B SUPER VOTING PREFERRED STOCK

of

CHAMPION PAIN CARE CORPORATION



Champion Pain Care Corporation, a Delaware corporation (the “Corporation”), hereby certifies that, pursuant to the authority conferred upon the Board of Directors of the Corporation (the “Board”) by its Articles of Incorporation, on November 10, 2016, the Board duly adopted the following resolution providing for the authorization of one (1) share of the Corporation’s Series B Super Voting Preferred Stock (the “Series B Super Voting Preferred Stock”):


RESOLVED, that pursuant to the authority vested in the Board by the Corporation’s Articles of Incorporation, the Board hereby establishes from the Corporation’s authorized class of preferred stock a new series to be known as “Series B Super Voting Preferred Stock,” consisting of One (1) share, and hereby determines the designation, preferences, rights, qualifications, limitations and privileges of the Series B Super Voting Preferred Stock of the Corporation to be as follows:

1.

Designation and Amount; Designated Holder.  Of the Ten Million and One (10,000,001) shares of the Company’s authorized Preferred Stock, $0.0001 par value per share, One (1) share is designated as “Series B Super Voting Preferred Stock,” with the rights and preferences set forth below. Only one person or entity is entitled to be designated as the owner of all of the Series B Super Voting Preferred Stock (the “Holder”), in whose name the initial certificates representing the Series B Super Voting Preferred Stock shall be issued. Any transfer of the Series B Super Voting Preferred Stock to a different Holder must be approved in advance by the Corporation; provided, however, the Holder shall have the right to transfer the Series B Super Voting Preferred Stock, or any portion thereof, to any affiliate of Holder or nominee of Holder, without the approval of the Corporation.

2.

Rank.  The Series B Super Voting Preferred Stock shall rank: (i) senior to all of the Common Stock, par value $0.0001 per share, of the Corporation (“Common Stock”); (ii) senior to all other classes or series of capital stock of the Corporation currently outstanding (other than Series A preferred Stock) or that specifically provide that it ranks junior to any Series B Super Voting Preferred Stock (collectively, with the Common Stock, “Junior Securities”); and (iii) junior to the Series A Preferred Stock of the Corporation and any other class or series of capital stock of the Corporation which specifically provides that it will rank senior in preference or priority to the Series B Super Voting Preferred Stock (“Senior Securities”), in each case as to distribution of any asset or property of the Corporation upon liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary (all such distributions being referred to as “Distributions”).

3.

Voting Rights.  The Holder of the Series B Super Voting Preferred Stock shall be entitled to vote on all matters subject to a vote or written consent of the holders of the Corporation’s Common Stock, and on all such matters, the share of Series B Super Voting Preferred Stock shall be entitled to that number of votes equal to the number of votes that all issued and outstanding shares of Common Stock and all other securities of the Corporation are entitled to, as of any such date of determination, on a fully diluted basis, plus one million (1,000,000) votes, it being the intention that the Holder of the Series B Super Voting Preferred Stock shall have effective voting control of the Corporation, on a fully diluted basis.  The Holder  of  the Series B Super  Voting Preferred  Stock shall  vote together  with the holders of Common Stock as a single class.

4.

Covenants.


(a)

The Corporation shall not amend, alter, change or repeal the preferences, privileges, special rights or other powers of the Series B Super Voting Preferred Stock so as to adversely affect the Series B Super Voting Preferred Stock, without the written consent of the Holder.

(b)

So long as shares of Series B Super Voting Preferred Stock are outstanding, the Corporation shall not, without first obtaining the approval (by vote or written consent, as provided by law) of Holder, which consent may be withheld in the Holder’s sole and absolute discretion: (i) dissolve the Corporation or effectuate a liquidation; (ii) alter, amend, or repeal the Certificate of Incorporation of the Corporation; (iii) agree to any provision in any agreement that would impose any restriction on the Corporation’s ability to honor the exercise of any rights of the Holder of the Series B Super Voting Preferred Stock; (iv) do any act or thing not authorized or contemplated by this Certificate which would result in taxation of the Holder of shares of the Series B Super Voting Preferred Stock under Section 305 of the Internal Revenue Code of 1986, as amended (or any comparable provision of the Internal Revenue Code as hereafter from time to time amended); or (v) issue any securities of the Corporation of any nature or kind, including securities convertible into any capital stock of the Corporation.

1.

Dividends.  The Holder of the Series B Super Voting Preferred Stock will not be entitled to participate with the holders of Common Stock in any dividends.

2.

Board Rights.  The Holder of the Series B Super Voting Preferred Stock, voting as a separate class, shall be entitled to elect one (1) individual to the Board of Directors of the Corporation (the “Series B Director”).   The Series B Director may be removed at any time as a director on the Board (with or without cause) upon, and only upon, the written request of the Holder of the Series B Super Voting Preferred Stock.  In the event that a vacancy is created on the Board at any time due to the death, disability, retirement, resignation or removal of the Series B Director, then the Holder of the Series B Super Voting Preferred Stock shall have the right to designate an individual to fill such vacancy. In the event that the Holder of the Series B Super Voting Preferred Stock shall fail to designate in writing a representative to fill the vacant Series B Director seat on the Board, then such Board seat shall remain vacant until such time as the Holder of the Series B Super Voting Preferred Stock elects an individual to fill such seat in accordance with this Section 6, and during any period where such seat remains vacant, the Board nonetheless shall be deemed duly constituted.

3.

Rights Subject to Credit Agreement.  The Series B Super Voting Preferred Stock is being issued to Holder in connection with that certain Credit Agreement between the Corporation, as borrower, and Holder, as lender, among others, dated as of March 31, 2016, and made effective as of December 1, 2016 (such Credit Agreement, as same may be amended, renewed, supplemented, or otherwise modified from time to time, the “Credit Agreement”).  The Series B Super Voting Preferred Stock shall be subject to the terms and conditions of the Credit Agreement relating to the Series B Super Voting Preferred Stock, including, without limitation, the adjustment provisions, mandatory redemption provisions, and other provisions set forth in the Credit Agreement.

4.

Severability.  If any right, preference or limitation of the Series B Super Voting Preferred Stock set forth herein is invalid, unlawful or incapable of being enforced by reason of any rule, law or public policy, all other rights, preferences and limitations set forth herein that can be given effect without the invalid, unlawful or unenforceable right, preference or limitation shall nevertheless remain in full force and effect, and no right, preference or limitation herein shall be deemed dependent upon any other such right, preference or limitation unless so expressed herein.

5.

Amendment and Waiver.  This Certificate of Designation shall not be amended, either directly or indirectly or through merger or consolidation with another entity, in any manner that would alter or change the powers, preferences or special rights of the Series B Super Voting Preferred Stock so as to affect them materially and adversely without the consent of the Holder.  Subject to the preceding sentence, any amendment, modification or waiver of any of the terms or provisions of the Series B Super Voting Preferred Stock shall be binding upon the Holder.

6.

Replacement.  Upon receipt of evidence reasonably satisfactory to the Corporation (an affidavit of the registered Holder shall be satisfactory) of the ownership and the loss, theft, destruction, or mutilation of any certificate evidencing shares of Series B Super Voting Preferred Stock, and in the case of any such loss, theft or destruction upon receipt of indemnity reasonably satisfactory to the Corporation (provided that if the Holder is a financial institution or other institutional investor its own agreement shall be satisfactory) or in the case of any such mutilation upon surrender of such certificate, the Corporation, at its expense, shall execute and deliver in lieu of such certificate a new certificate of like kind representing the number of shares of such Series represented by such lost, stolen, destroyed or mutilated certificate and dated the date of such lost, stolen, destroyed or mutilated certificate.

7.

Notices.  Any notice required by the provisions of this Certificate of Designation shall be given in accordance with the terms of the Credit Agreement.

8.

Cumulative Remedies.  Nothing contained in this Certificate of Designations shall prohibit, prevent, or otherwise preclude Holder from enforcing the Credit Agreement and other “Loan Documents” (as defined in the Credit Agreement) and its rights and remedies thereunder, through any and all other rights and remedies available to Holder under the Credit Agreement and all other Loan Documents, it being acknowledged by the Corporation that the rights and preferences of the Series B Super Voting Preferred Stock are in addition to all other rights and remedies available to Holder under the Credit Agreement and other Loan Documents.


* * * * *

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Designation to be executed by Terrance Owen, CFO of the Corporation, this 1st day of December, 2016.




By:

/s/ Terrance Owen

Name:

Terrance Owen

Title:

CFO